Skip to main content
The Morning Star Shop
Drug shown to slow Alzheimer’s deemed too costly for NHS
An elderly woman's hands

THE Health Secretary was urged today to help the NHS get “fit for the future of dementia” after it emerged that a drug shown to slow Alzheimer’s may not be available on the NHS because of its cost.

Trials found that the drug Lecanemab could slow cognitive decline in early-stage Alzheimer’s patients by 27 per cent over 18 months.

Though approved by the Medicines and Healthcare products Regulatory Agency, the healthcare spending watchdog gave a provisional decision denying access to the treatment on the NHS. 

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
Maysara Adwan, left, mourns as she holds the body of her 11-year-old son, Qais, who was killed in an Israeli airstrike on a school in Gaza that has been used as a shelter, during his burial at Al Shifa Hospital in Gaza City, Friday, July 25, 2025
Arms Trade / 25 July 2025
25 July 2025

Sir Keir faces backlash for continuing to enable the genocide in Gaza

Pic: Neil Terry
Britain / 25 July 2025
25 July 2025

 Birmingham’s striking bin workers and supporters bring waste sites to a standstill

Similar stories
(left to right) Health Secretary Wes Streeting, Dr James Mar
Britain / 9 April 2025
9 April 2025
Labour warned that workers expect better as anger mounts over welfare cuts and public-sector pay
Health Secretary Wes Streeting with Prime Minister Keir Star
Britain / 17 February 2025
17 February 2025